Literature DB >> 29570886

Lysosomal LAMP1 immunoreactivity exists in both diffuse and neuritic amyloid plaques in the human hippocampus.

Sofia Hassiotis1, Jim Manavis2, Peter C Blumbergs2, Kathryn J Hattersley1, Julian M Carosi1,3, Makoto Kamei1, Timothy J Sargeant1,4.   

Abstract

Lysosomal vesicles around neuritic plaques are thought to drive Alzheimer's disease by providing ideal microenvironments for generation of amyloid-β. Although lysosomal vesicles are present at every amyloid plaque in mouse models of Alzheimer's disease, the number of amyloid plaques that contain lysosomal vesicles in the human brain remains unknown. This study aimed to quantify lysosomal vesicles at amyloid plaques in the human hippocampus. Lysosome-associated membrane protein 1 (LAMP1)-positive vesicles accumulated in both diffuse (Aβ42-positive/AT8-negative) and neuritic (Aβ42-positive/AT8-positive) plaques in all regions were analysed. In contrast to mouse models of Alzheimer's disease, however, not all amyloid plaques accumulated LAMP1-positive lysosomal vesicles. Even at neuritic plaques, LAMP1 immunoreactivity was more abundant than phospho-tau (AT8). Further, lysosomal vesicles colocalised weakly with phospho-tau such that accumulation of lysosomal vesicles and phospho-tau appeared to be spatially distinct events that occurred within dystrophic neurites. This quantitative study shows that diffuse plaques, as well as neuritic plaques, contain LAMP1 immunoreactivity in the human hippocampus.
© 2018 Federation of European Neuroscience Societies and John Wiley & Sons Ltd.

Entities:  

Keywords:  Alzheimer's disease; amyloid plaque; amyloid-β; lysosome; tau

Mesh:

Substances:

Year:  2018        PMID: 29570886     DOI: 10.1111/ejn.13913

Source DB:  PubMed          Journal:  Eur J Neurosci        ISSN: 0953-816X            Impact factor:   3.386


  10 in total

Review 1.  Neuropathological assessment of the Alzheimer spectrum.

Authors:  Kurt A Jellinger
Journal:  J Neural Transm (Vienna)       Date:  2020-08-01       Impact factor: 3.575

2.  Electroacupuncture ameliorates beta-amyloid pathology and cognitive impairment in Alzheimer disease via a novel mechanism involving activation of TFEB (transcription factor EB).

Authors:  Xiaoyan Zheng; Wenjia Lin; Yimin Jiang; Kejia Lu; Wenjing Wei; Qingwei Huo; Shaoyang Cui; Xifei Yang; Min Li; Nenggui Xu; Chunzhi Tang; Ju-Xian Song
Journal:  Autophagy       Date:  2021-02-23       Impact factor: 16.016

3.  Microglia use TAM receptors to detect and engulf amyloid β plaques.

Authors:  Youtong Huang; Kaisa E Happonen; Patrick G Burrola; Carolyn O'Connor; Nasun Hah; Ling Huang; Axel Nimmerjahn; Greg Lemke
Journal:  Nat Immunol       Date:  2021-04-15       Impact factor: 25.606

Review 4.  Hijacking Endocytosis and Autophagy in Extracellular Vesicle Communication: Where the Inside Meets the Outside.

Authors:  Giona Pedrioli; Paolo Paganetti
Journal:  Front Cell Dev Biol       Date:  2021-01-07

Review 5.  Gut Microbiome Regulation of Autophagic Flux and Neurodegenerative Disease Risks.

Authors:  Andrew P Shoubridge; Célia Fourrier; Jocelyn M Choo; Christopher G Proud; Timothy J Sargeant; Geraint B Rogers
Journal:  Front Microbiol       Date:  2021-12-23       Impact factor: 5.640

6.  Lysosomal gene Hexb displays haploinsufficiency in a knock-in mouse model of Alzheimer's disease.

Authors:  Lauren S Whyte; Célia Fourrier; Sofia Hassiotis; Adeline A Lau; Paul J Trim; Leanne K Hein; Kathryn J Hattersley; Julien Bensalem; John J Hopwood; Kim M Hemsley; Timothy J Sargeant
Journal:  IBRO Neurosci Rep       Date:  2022-01-20

7.  The amyloid plaque proteome in early onset Alzheimer's disease and Down syndrome.

Authors:  Eleanor Drummond; Tomas Kavanagh; Geoffrey Pires; Mitchell Marta-Ariza; Evgeny Kanshin; Shruti Nayak; Arline Faustin; Valentin Berdah; Beatrix Ueberheide; Thomas Wisniewski
Journal:  Acta Neuropathol Commun       Date:  2022-04-13       Impact factor: 7.578

8.  Retromer regulates the lysosomal clearance of MAPT/tau.

Authors:  Julian M Carosi; Leanne K Hein; Mark van den Hurk; Robert Adams; Bridget Milky; Sanjna Singh; Cedric Bardy; Donna Denton; Sharad Kumar; Timothy J Sargeant
Journal:  Autophagy       Date:  2020-09-22       Impact factor: 16.016

9.  TMEM59 Haploinsufficiency Ameliorates the Pathology and Cognitive Impairment in the 5xFAD Mouse Model of Alzheimer's Disease.

Authors:  Jian Meng; Linkun Han; Naizhen Zheng; Hui Xu; Zhaoji Liu; Xian Zhang; Hong Luo; Dan Can; Hao Sun; Huaxi Xu; Yun-Wu Zhang
Journal:  Front Cell Dev Biol       Date:  2020-10-28

Review 10.  The mTOR-lysosome axis at the centre of ageing.

Authors:  Julian M Carosi; Célia Fourrier; Julien Bensalem; Timothy J Sargeant
Journal:  FEBS Open Bio       Date:  2021-12-18       Impact factor: 2.693

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.